- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
The Trump administration may brag that drug makers are dialing back price hikes, but a company that makes an essential mineral used by hospitals for feeding patients intravenously recently
raised its price by a whopping 1,300%. Last month, American Regent began selling a product called Selenious Acid Injection, which is used for total parenteral nutrition, a way to provide
nutrients to patients who cannot eat food. Selenious Acid is an updated version of an older product called Selenium which, along with numerous other decades-old medicines, had never actually
been approved by the Food and Drug Administration. Responding to an FDA program to upgrade or replace old medicines, American Regent was granted agency approval last April for its new
version. Shortly afterwards, the company discontinued its older product and began charging a much higher price for the newer one. Specifically, a microgram of the older Selenium had cost 4.4
cents, but a microgram of Selenious Acid costs 57 cents. STAT+ Exclusive Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — PLUS
IN-DEPTH ANALYSIS, NEWSLETTERS, PREMIUM EVENTS, AND NEWS ALERTS. Already have an account? Log in Individual plans Group plans View All Plans To read the rest of this story subscribe to
STAT+. Subscribe
